Jack Kaye insider trades

Open-market stock purchases and sales by Jack Kaye, Director at uniQure NV, from SEC Form 4 filings since Jun 16, 2010.

Recent trades

DateStockTradeValue
Jun 17, 2026QURE uniQure NVSold$225K
Jun 17, 2026QURE uniQure NVBought (not open market)—
Jun 11, 2026QURE uniQure NVSold$53.9K
Jun 10, 2026QURE uniQure NVBought (not open market)—
Jun 10, 2026QURE uniQure NVBought (not open market)—
Jun 3, 2026QURE uniQure NVSold$79.4K
Jun 3, 2026QURE uniQure NVBought (not open market)—
Jan 9, 2026QURE uniQure NVSold$174K
Jan 9, 2026QURE uniQure NVBought (not open market)—
Jan 2, 2026DYAI Dyadic International IncBought (not open market)—
Jan 2, 2026DYAI Dyadic International IncBought (not open market)—
Jan 2, 2026DYAI Dyadic International IncBought (not open market)—
Nov 4, 2025QURE uniQure NVSold$304K
Nov 4, 2025QURE uniQure NVSold$334K
Nov 4, 2025QURE uniQure NVSold$540K
Nov 4, 2025QURE uniQure NVBought (not open market)—
Nov 4, 2025QURE uniQure NVBought (not open market)—
Nov 4, 2025QURE uniQure NVBought (not open market)—

Companies traded

  • QURE uniQure NV: 15 sales, last Jun 17, 2026
  • DYAI Dyadic International Inc: other filings, last Jan 2, 2026
  • KERX Keryx Biopharmaceuticals Inc: 2 sales, last Jun 17, 2015

Get free alerts when Jack Kaye files a new trade →